This inventor holds 2 USPTO granted patents. Top assignees: Otsuka Pharmaceutical Company, Limited, Otsuka Pharmaceutical Factory, Inc.. Active years: 1993-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Otsu, JP (1993)
- Kusatsu, JP (2001)
Company Filing History:


Years Active: 1993-2001
Title: Naosumi Kinoshita: Innovator in Pharmaceutical Chemistry
Introduction
Naosumi Kinoshita is a notable inventor based in Otsu, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Kinoshita has focused on developing novel compounds that have important medical applications.
Latest Patents
Kinoshita's latest patents include a pyrimidine derivative and polypeptide derivatives aimed at improving calcium metabolism. The pyrimidine derivative is represented by a specific general formula, showcasing its unique chemical structure. The polypeptide derivatives are designed to inhibit bone calcium absorption and lower blood calcium levels. These compounds also serve as analgesics and can be formulated into pharmaceutical compositions that are effective in treating conditions such as hypercalcemia, Paget's disease, and osteoporosis.
Career Highlights
Throughout his career, Kinoshita has worked with prominent companies in the pharmaceutical industry, including Otsuka Pharmaceutical Company, Limited and Otsuka Pharmaceutical Factory, Inc. His work has been instrumental in advancing the development of therapeutic agents that address critical health issues.
Collaborations
Kinoshita has collaborated with esteemed colleagues such as Satoshi Yamada and Koichi Yasumura. These partnerships have contributed to the successful development of his innovative pharmaceutical solutions.
Conclusion
Naosumi Kinoshita's contributions to pharmaceutical chemistry through his patents highlight his role as an influential inventor. His work continues to impact the medical field positively, providing solutions for various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile